John Maraganore Insider Profile
18 Followers
John Maraganore, Director at Takeda Pharmaceutical Company, holds 24.20K shares in Takeda Pharmaceutical Company (Ticker: TAK), holds 230.80K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Beam Therapeutics (Ticker: BEAM).
John Maraganore Takeda Pharmaceutical Company (TAK)Director
Takeda Pharmaceutical Company (TAK)
Director
Ranked #2,418 out of 109,030 Corporate Insiders
Profitable Transactions
7 out of 14 Profitable Transactions
Average Return
+47.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Maraganore holds in companies
Most Profitable Insider Trade
Stock:
Bluebird Bio
(BLUE)
(BLUE)
Rating:Informative Buy
Date:Jul 14, 2014 - Jul 14, 2015
Return:+386.00%
The most profitable trade made by John Maraganore
John Maraganore's Trading History
Takeda Pharmaceutical Company
Jul 06, 2026
Director
Uninformative Buy
―
$441.89K
Alnylam Pharma
Dec 23, 2021
CEO, Director
Uninformative Buy
―
$57.39M
Beam Therapeutics
―
Director
―
―
Kymera Therapeutics
―
Director
―
―
ProKidney
―
Director
―
―
Rapport Therapeutics, Inc.
―
Director
―
―
Hemab Therapeutics Holdings, Inc.
May 04, 2026
Director
Uninformative Buy
―
$1.42M
Agios Pharma
May 24, 2022
Director
Uninformative Buy
33.44K
$1.01M
Bluebird Bio
Sep 18, 2017
―
Uninformative Buy
39.43K
$29.04K
Regulus
Oct 11, 2012
―
Uninformative Buy
―
$50.19M
List of latest transactions for each holding click on a transaction to see John Maraganore's performance on stock
You May Also Like
John Maraganore insider profile FAQ
What is the percentage of profitable transactions made by John Maraganore?
The percentage of profitable transactions made by John Maraganore is 50%.
What is the average return per transaction made by John Maraganore?
The average return per transaction made by John Maraganore is 47.10%.
What stocks does John Maraganore hold?
John Maraganore holds: TAK, ALNY, BEAM, KYMR, PROK, RAPP, COAG, AGIO, BLUE, RGLS stocks.
What was John Maraganore’s latest transaction?
John Maraganore latest transaction was an Uninformative Buy of ―.
What was John Maraganore's most profitable transaction?
John Maraganore’s most profitable transaction was an Informative Buy of BLUE stock on July 14, 2014. The return on the trade was 386.00%.
What is John Maraganore's role in Takeda Pharmaceutical Company?
John Maraganore's role in Takeda Pharmaceutical Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.